Effect of Spironolactone on ventricular arrhythmias in congestive heart failure secondary to idiopathic dilated or to ischemic cardiomyopathy

The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure

1999 • 8,588 citations

Mortality and Morbidity in Patients Receiving Encainide, Flecainide, or Placebo

1991 • 3,106 citations

The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure

2000 • 2,991 citations

Amiodarone in Patients with Congestive Heart Failure and Asymptomatic Ventricular Arrhythmia

1995 • 1,199 citations

Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. CONSENSUS Trial Study Group.

1990 • 1,151 citations

Remodeling of the rat right and left ventricles in experimental hypertension.

1990 • 676 citations

Myocardial fibrosis: functional significance and regulatory factors

1993 • 484 citations

Anti-Aldosterone Treatment and the Prevention of Myocardial Fibrosis in Primary and Secondary Hyperaldosteronism

1993 • 432 citations

Captopril in heart failure. A double blind controlled trial.

1984 • 385 citations

RISE IN PLASMA CONCENTRATION OF ALDOSTERONE DURING LONG-TERM ANGIOTENSIN II SUPPRESSION

1981 • 330 citations

Effect of amiodarone on mortality after myocardial infarction: A double-blind, placebo-controlled, pilot study

1992 • 300 citations

Antifibrotic effects of spironolactone in preventing myocardial fibrosis in systemic arterial hypertension

1993 • 275 citations

Arrhythmias and mortality in congestive heart failure

1990 • 259 citations

Antihypertensive therapy with MK 421: angiotensin II--renin relationships to evaluate efficacy of converting enzyme blockade.

1982 • 243 citations

Antihypertensive Therapy with MK 4211

1982 • 188 citations

Increased cardiac types I and III collagen mRNAs in aldosterone-salt hypertension.

1994 • 179 citations

Biological Determinants of Aldosterone-Induced Cardiac Fibrosis in Rats

1995 • 173 citations

The inverse relationship between baseline left ventricular ejection fraction and outcome of antiarrhythmic therapy: A dangerous imbalance in the risk-benefit ratio

1989 • 116 citations

Aldosterone and antialdosterone therapy in congestive heart failure

1993 • 110 citations

Aldosterone escape during ACE inhibitor therapy in chronic heart failure

1995 • 109 citations

Mechanism of the antimineralocorticoid effects of spirolactones

1981 • 86 citations

Relations between heart failure, ejection fraction, arrhythmia suppression and mortality: Analysis of the Cardiac Arrhythmia Suppression Trial

1995 • 81 citations

Distribution of 11 beta-hydroxysteroid dehydrogenase along the rabbit nephron.

1990 • 80 citations

Captopril in heart failure.

1988 • 50 citations

Aldosterone antagonists destabilize the mineralocorticosteroid receptor

1992 • 45 citations

Relation of cardiovascular disease to potassium and magnesium deficiencies

1990 • 43 citations

Angiotensin-converting enzyme inhibitor and spironolactone combination therapy

1993 • 39 citations

Ventricular arrhythmias in heart failure

1992 • 33 citations

Effect of a spirolactone derivative, sodium canrenoate, on mechanical and electrical activities of isolated rat myocardium.

1974 • 30 citations

Chronic mineralocorticoid excess and cardiovascular remodeling

1995 • 30 citations

Exercise Training for Patients with Coronary Artery Disease

1992 • 25 citations

Magnesium and cardiovascular drugs: interactions and therapeutic role.

1999 • 25 citations

Sudden Death in Patients With Congestive Heart Failure: Future Directions

1992 • 15 citations

Deleted Work

1955 • 0 citations